End-stage liver disease is known to cause hormonal dysregulation in both men and women. Reproductive-aged women with cirrhosis typically have secondary amenorrhoea, 1 while peripheral conversion of androgens to oestrogens and increase in sex hormone binding globulin (SHBG) levels, contributes to feminization of cirrhotic men.
Summary
Cirrhosis is associated with hormonal dysregulation, as evidenced by secondary amenorrhoea in reproductive-aged women, and feminization of cirrhotic men. Compared to non cirrhotics, cirrhotic women had higher oestradiol (11.0 vs 6.0 pg/ mL, P = 0.05) and oestrone levels (32.0 vs 8.0 ng/mL, P < 0.001), and lower sex hormone binding globulin (SHBG) (69.2 vs 155.6 nmol/L, P = 0.001), and FSH levels (4.9 vs 89.6 mIU/mL, P < 0.001). Among cirrhotic women, there was a progressive decline in FSH and SHBG and concurrent rise in oestrone levels from CTP class A to C (test of trend, P values ≤0.02). Cirrhosis is associated with lower FSH and SHBG levels in cirrhotic compared to noncirrhotic women with HCV infection. In cirrhotic women, these levels demonstrate steady decline by disease severity. Given known associations of low SHBG and FSH with cardio-metabolic disease, the clinical implications of hormonal changes by cirrhosis severity in HCV-infected women warrants investigation.
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of liver disease, with the most profound changes among men with greater severity of liver dysfunction. In healthy women, menopause normally leads to declining oestradiol levels and rise in FSH, which are associated with risk of cardiac 4 and bone disease, 5 respectively.
Less is known about the effect of cirrhosis on sex hormone production and metabolism in post-menopausal women, including whether hormone levels vary by severity of cirrhosis resulting from chronic hepatitis C virus (HCV) infection.
In order to address existing knowledge gaps, we aimed to com- 
| ME THODS

| Study design and study patients
We conducted a cross-sectional study of post-menopausal women with chronic HCV infection, conducted at two study sites, the categorized by CTP class. 6 Study participants underwent banking of blood within 6 months of fibrosis assessment. These specimens were used for sex hormone measurements as noted below.
| Sex hormone assays
Sex hormone assays in duplicate batches were performed at the laboratory of the Wisconsin National Primate Research Center.
Oestradiol, oestrone, dehydroepiandrosterone sulphate (DHEAS), androstenedione, total testosterone and progesterone were measured by a multi-steroid liquid chromatography tandem mass spectrometry (LC/MS/MS) method. 7 FSH and SHBG were measured using commercial enzyme-linked immunosorbent assay (ELISA). Four women with prior oophorectomy were excluded from analyses of all sex hormones except for oestrone, DHEAS, and SHBG, as oophorectomy is not anticipated to affect these three hormone levels. There were an additional two women with exogenous oestradiol use that were excluded from analyses of oestradiol, oestrone, SHBG and FSH levels given potential effect of exogenous oestradiol use on these specific hormone levels. Interassay coefficient of variation was 3.7%
for oestradiol, 8.7% for oestrone, 11.2% for DHEAS, 10.8% for androstenedione, 9.9% for testosterone, 6.1% for progesterone, 12.6%
for FSH and 4.6% for SHBG.
| Statistical analysis
Categorical variables were summarized by frequencies and pro- Approval was obtained from the institutional review boards at the two study sites. Informed consent was obtained from all patients to be included in this study.
| RE SULTS
The study cohort included 18 cirrhotic and 21 noncirrhotic women with chronic HCV infection. The median age was 57 years (IQR 53-62); 61% were White, 27% Black and 12% Hispanic with similar age and race/ethnicity by cirrhosis status (P values ≥ 0.40). There were no cirrhotic patients with current alcohol use, and among the six noncirrhotic women reporting current use, all consumed ≤2 alcoholic drinks per day.
Oestrogen levels were higher in cirrhotic compared to noncirrhotic women, including higher median oestradiol levels 
| D ISCUSS I ON
In the current study, we identified changes in a comprehensive panel of sex hormones, not only by presence of cirrhosis, but also across severity of cirrhosis as defined by CTP class. Notably, oestrogen levels, including oestradiol and oestrone, were higher in cirrhotic women, while FSH and SHBG levels were conversely lower. These changes were pronounced across severity of liver disease with rising oestrone levels as well as declining SHBG and FSH with increasing CTP class.
The clinical implications of the current findings warrant further investigation. Oestrogens are known for their cardio-protective effects, although it is not known whether higher oestrogen levels in the context of cirrhosis confer any decrease in cardiovascular risk. Importantly, low SHBG has been associated with increased risk of dyslipidemia, insulin resistance, and diabetes mellitus in postmenopausal women, independent of oestrogen levels. 9,10 Low SHBG has also been shown to be associated with risk of nonalcoholic fatty liver disease (NAFLD) in post-menopausal women, regardless of oestrogen levels. 11, 12 This association may relate to the direct SHBG effect on hepatic lipogenic enzyme activity. 11, 12 Whether low SHBG may also be a marker of metabolic risk in individuals with cirrhosis is not known.
Like SHBG, low FSH levels are also associated with obesity, diabetes mellitus, as well as risk of NAFLD in post-menopausal women, largely independent of oestrogen levels. 13, 14 Recent data specifically highlight the association of low FSH on risk of CAD in post-menopausal women, which may relate to the pro-angiogenic activity of FSH. 15 We also identified lower DHEAS in cirrhotic women, a finding which has been observed in other forms of advanced liver, such as advanced NASH fibrosis. 16 Interestingly, in women with hypoadrenalism, DHEA replacement has been shown to improve insulin sensitivity, suggesting its potential contribution to glucose homoeostasis and cardio-metabolic health. 17 The reasons for altered sex hormones in cirrhosis are complex and include impairment at the level of the hypothalamus, with decreased levels of gonadotropin releasing hormone, as well as impaired release of FSH and luteinizing hormone from the anterior TA B L E 1 Sex hormone levels in post-menopausal women with chronic hepatitis C infection by presence and severity of cirrhosis pituitary. 18, 19 Despite the presence of hypogonadotropic hypogonadism, higher circulating levels of oestradiol are evident in cirrhosis, due primarily to increased peripheral conversion of androgens to oestrogens. 20, 21 Prior data from male predominant cohorts do note higher levels of SHBG in patients with cirrhosis, as compared to healthy controls, 22 which may also contribute to feminization of cirrhotic men. In contrast, we observed lower SHBG levels by presence and severity of cirrhosis which likely reflects differences in study population, as the current analysis compares SHBG levels within a post-menopausal population, all of whom had chronic HCV infection. Similar to our study, lower SHBG levels have been observed in men with decompensated as compared to compensated cirrhosis from nonalcoholic causes of liver disease, 22 suggestive of impaired hepatic production of SHBG, with more severe liver disease. 25 with an emerging epidemic of de novo NAFLD after transplant. 26, 27 Whether an adverse hormonal profile during the pretransplant cirrhotic years could set the stage for post-transplant metabolic disease warrants investigation.
There were notable strengths and limitations of the current study. Despite the small sample size, statistically significant differences in sex hormone levels by cirrhosis status were nonetheless identified. However, larger subgroups of women within each CTP class, would have allowed for more robust comparisons of hormone measures. Given the cross-sectional nature of our study, we did not evaluate how the observed changes in hormone levels may affect the development of subsequent metabolic comorbidities. However, the current findings support the need for future studies evaluating metabolic disease in women with liver disease to consider sex hormone levels.
In summary, we identified changes in sex hormone profiles between cirrhotic and noncirrhotic women with chronic HCV infection. There were higher oestrogen levels, as well as lower SHBG and 
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